The Asia Pacific Nerve Repair and Regeneration Market is expected to witness market growth of 7.1% CAGR during the forecast period (2022-2028).
Stem cell treatment for nerve injury has a lot of potential, and it has a lot of advantages over other, more conventional therapies like surgery. It has been shown in studies to lessen overall peripheral nerve damage while also promoting tissue regeneration. This therapy may restore total functional recovery in some cases, but not all. Damage to the neurological system can be caused by a variety of factors. Diabetic patients may develop numbness as a result of neuropathy caused by long-term elevated blood sugar levels. Chemotherapy with some types of drugs can be hazardous to healthy nerve tissue. Herpes zoster is one of several viral diseases that can cause nerve damage. Finally, nerve injury is common in automobile accidents and other types of trauma.
These advancements are being achieved in peripheral nerve surgery, and a new surgical discipline including peripheral neurosurgery reconstruction is emerging. Neurosurgery, orthopaedics, hand and plastic surgery, and neurology, spinal injuries, neurophysiology, and rehabilitation medicine are just a few of the surgical disciplines involved in peripheral nerve surgery. Nerve decompression, graft reconstruction, microsurgical repair, neurolysis, and nerve transfer operations may be necessary by surgeons. When paralysis is long-term or not responsive to a main nerve treatment, tendon transfer, arthrodesis, and functioning free muscle transfers is used.
Alzheimer's disease and other kinds of dementia are becoming more common among the elderly in emerging countries, where the population is rapidly ageing. By 2020, it is anticipated that 70 percent of the world's population aged 60 and up is expected to be residing in emerging economies, with India accounting for 14.2 percent. Only prospective incidence studies can provide accurate estimates of the rate about which new disease develops. Incidence rates of Alzheimer's disease have been found to be lower in Asian nations than in the industrialized world. Despite the availability of dementia prevalence research from Asian nations such as India, there is a scarcity of incidence data, especially from selective long-term studies.
As part of the cognitive in older adults in Trivandrum (COAT) project, researchers previously reported that the age-adjusted prevalence of dementia, including Alzheimer's disease, was 4.86 percent in a community living population in the southern Indian province of Kerala. The incidence rates of the COAT cohort after a ten-year follow-up are reported in this study. With the rising cases of these diseases and increasing R&D activities for improving nerve repair and regeneration solutions, the demand and growth of regional market is expected to witness a spur in the coming years.
The China market dominated the Asia Pacific Nerve Repair and Regeneration Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $632.2 Million by 2028. The Japan market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 7.7% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
Stem cell treatment for nerve injury has a lot of potential, and it has a lot of advantages over other, more conventional therapies like surgery. It has been shown in studies to lessen overall peripheral nerve damage while also promoting tissue regeneration. This therapy may restore total functional recovery in some cases, but not all. Damage to the neurological system can be caused by a variety of factors. Diabetic patients may develop numbness as a result of neuropathy caused by long-term elevated blood sugar levels. Chemotherapy with some types of drugs can be hazardous to healthy nerve tissue. Herpes zoster is one of several viral diseases that can cause nerve damage. Finally, nerve injury is common in automobile accidents and other types of trauma.
These advancements are being achieved in peripheral nerve surgery, and a new surgical discipline including peripheral neurosurgery reconstruction is emerging. Neurosurgery, orthopaedics, hand and plastic surgery, and neurology, spinal injuries, neurophysiology, and rehabilitation medicine are just a few of the surgical disciplines involved in peripheral nerve surgery. Nerve decompression, graft reconstruction, microsurgical repair, neurolysis, and nerve transfer operations may be necessary by surgeons. When paralysis is long-term or not responsive to a main nerve treatment, tendon transfer, arthrodesis, and functioning free muscle transfers is used.
Alzheimer's disease and other kinds of dementia are becoming more common among the elderly in emerging countries, where the population is rapidly ageing. By 2020, it is anticipated that 70 percent of the world's population aged 60 and up is expected to be residing in emerging economies, with India accounting for 14.2 percent. Only prospective incidence studies can provide accurate estimates of the rate about which new disease develops. Incidence rates of Alzheimer's disease have been found to be lower in Asian nations than in the industrialized world. Despite the availability of dementia prevalence research from Asian nations such as India, there is a scarcity of incidence data, especially from selective long-term studies.
As part of the cognitive in older adults in Trivandrum (COAT) project, researchers previously reported that the age-adjusted prevalence of dementia, including Alzheimer's disease, was 4.86 percent in a community living population in the southern Indian province of Kerala. The incidence rates of the COAT cohort after a ten-year follow-up are reported in this study. With the rising cases of these diseases and increasing R&D activities for improving nerve repair and regeneration solutions, the demand and growth of regional market is expected to witness a spur in the coming years.
The China market dominated the Asia Pacific Nerve Repair and Regeneration Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $632.2 Million by 2028. The Japan market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 7.7% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Surgery
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
- Stem Cell Therapy
By Product
- Neuromodulation Surgery Devices
- Biomaterials
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Integra Lifesciences Corporation
- Medtronic PLC
- Axogen, Inc.
- Stryker Corporation
- Checkpoint Surgical, Inc.
- Polyganics BV
- Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- OrthoMed, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Nerve Repair and Regeneration Market by Surgery
Chapter 5. Asia Pacific Nerve Repair and Regeneration Market by Product
Chapter 6. Asia Pacific Nerve Repair and Regeneration Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Integra Lifesciences Corporation
- Medtronic PLC
- Axogen, Inc.
- Stryker Corporation
- Checkpoint Surgical, Inc.
- Polyganics BV
- Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- OrthoMed, Inc.
Methodology
LOADING...
